| Authors: |
Stone M; Blood Systems Research Institute, San Francisco, California, USA mstone@bloodsystems.org.; Department of Laboratory Medicine, University of California, San Francisco, California, USA., Bainbridge J; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, USA.; Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA., Sanchez AM; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, USA.; Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA., Keating SM; Blood Systems Research Institute, San Francisco, California, USA.; Department of Laboratory Medicine, University of California, San Francisco, California, USA., Pappas A; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, USA.; Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA., Rountree W; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, USA.; Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA., Todd C; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, USA.; Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA., Bakkour S; Blood Systems Research Institute, San Francisco, California, USA.; Department of Laboratory Medicine, University of California, San Francisco, California, USA., Manak M; Henry M. Jackson Foundation, Silver Spring, Maryland, USA., Peel SA; MHRP, Walter Reed Army Institute of Research (WRAIR), Silver Spring, Maryland, USA., Coombs RW; Department of Laboratory Medicine, University of Washington, Seattle, Washington, USA., Ramos EM; Department of Laboratory Medicine, University of Washington, Seattle, Washington, USA., Shriver MK; Bio-Rad Laboratories, Redmond, Washington, USA., Contestable P; Ortho Clinical Diagnostics, Rochester, New York, USA., Nair SV; Hologic, Inc., San Diego, California, USA., Wilson DH; Quanterix, Lexington, Massachusetts, USA., Stengelin M; MesoScale Discovery, Rockville, Maryland, USA., Murphy G; Public Health England, London, United Kingdom., Hewlett I; Center for Biologic Evaluation and Research (CBER), U.S. Food and Drug Administration (FDA), Bethesda, Maryland, USA., Denny TN; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, USA.; Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA., Busch MP; Blood Systems Research Institute, San Francisco, California, USA.; Department of Laboratory Medicine, University of California, San Francisco, California, USA. |
